Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Giuseppe, Bronte"'
Autor:
Sara Cecchini, Cristina Gatti, Daniela Fornarelli, Lorenzo Fantechi, Cinzia Romagnolo, Elena Tortato, Anna Rita Bonfigli, Roberta Galeazzi, Fabiola Olivieri, Giuseppe Bronte, Enrico Paci
Publikováno v:
Tomography, Vol 10, Iss 8, Pp 1312-1319 (2024)
Background: Distinguishing between Charcot Neuroarthropathy (CN), osteomyelitis (OM), and CN complicated with superimposed OM in diabetic patients is crucial for the treatment choice. Given that current diagnostic methods lack specificity, advanced t
Externí odkaz:
https://doaj.org/article/777ccd3c6e7b46cfb866666e14df65bc
DNA Methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes
Autor:
Jacopo Sabbatinelli, Angelica Giuliani, Katarzyna Malgorzata Kwiatkowska, Giulia Matacchione, Alessia Belloni, Deborah Ramini, Francesco Prattichizzo, Valeria Pellegrini, Francesco Piacenza, Elena Tortato, Anna Rita Bonfigli, Davide Gentilini, Antonio Domenico Procopio, Paolo Garagnani, Fabiola Olivieri, Giuseppe Bronte
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-13 (2024)
Abstract Background Individuals with type 2 diabetes (T2D) face an increased mortality risk, not fully captured by canonical risk factors. Biological age estimation through DNA methylation (DNAm), i.e. the epigenetic clocks, is emerging as a possible
Externí odkaz:
https://doaj.org/article/b6d21c1ac84e47bc9de7a862c4f4cc02
Autor:
Luana Calabrò, Giuseppe Bronte, Federica Grosso, Luigi Cerbone, Angelo Delmonte, Fabio Nicolini, Massimiliano Mazza, Anna Maria Di Giacomo, Alessia Covre, Maria Fortunata Lofiego, Lucio Crinò, Michele Maio
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Pleural mesothelioma (PM) is an aggressive and rare disease, characterized by a very poor prognosis. For almost two decades, the world standard treatment regimen for unresectable PM has consisted of a platinum-based drug plus pemetrexed, leading to a
Externí odkaz:
https://doaj.org/article/8927fd98d7b248cbac772e012b06e713
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
Externí odkaz:
https://doaj.org/article/2d089392ca0e43ac9eda67cf4918da8e
Autor:
Lorenza Tamberi, Alessia Belloni, Armanda Pugnaloni, Maria Rita Rippo, Fabiola Olivieri, Antonio Domenico Procopio, Giuseppe Bronte
Publikováno v:
Cells, Vol 13, Iss 7, p 643 (2024)
The neuro-immune axis has a crucial function both during physiological and pathological conditions. Among the immune cells, myeloid-derived suppressor cells (MDSCs) exert a pivotal role in regulating the immune response in many pathological condition
Externí odkaz:
https://doaj.org/article/0e5b80d773524bda9788c8aee3092408
Autor:
Giuseppe Bronte, Elisabetta Petracci, Serena De Matteis, Matteo Canale, Ilaria Zampiva, Ilaria Priano, Paola Cravero, Kalliopi Andrikou, Marco Angelo Burgio, Paola Ulivi, Angelo Delmonte, Lucio Crinò
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundImmunotherapy has become the standard of care for non-small cell lung cancer (NSCLC) patients. Some patients experience primary resistance to immunotherapy. Currently, we lack a marker of resistance to immunotherapy. Myeloid-derived suppres
Externí odkaz:
https://doaj.org/article/0de34580c9a141de9b865d68fa2f0987
Autor:
Roberta Maltoni, Sara Ravaioli, Giuseppe Bronte, Massimiliano Mazza, Claudio Cerchione, Ilaria Massa, William Balzi, Michela Cortesi, Michele Zanoni, Sara Bravaccini
Publikováno v:
Translational Oncology, Vol 15, Iss 1, Pp 101300- (2022)
Ma and colleagues reported in their study on 12,004 elderly patients published on Breast J. 2020, that adjuvant chemotherapy was not associated with overall survival. Given the toxicities associated with systemic treatments, caution recommendation or
Externí odkaz:
https://doaj.org/article/48243069127b4c598fed7ca309fde0fd
Autor:
Sara Bravaccini, Giuseppe Bronte, Elisabetta Petracci, Maurizio Puccetti, Manolo D’Arcangelo, Sara Ravaioli, Maria Maddalena Tumedei, Roberta Maltoni, Angelo Delmonte, Federico Cappuzzo, Lucio Crinò
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Programmed death ligand 1 (PD-L1) is an immune checkpoint with a role in cancer-related immune evasion. It is a target for cancer immunotherapy and its expression is detected for the use of some immune checkpoint inhibitors in advanced non-small cell
Externí odkaz:
https://doaj.org/article/db302667216f4985b2e27f223631df39
Autor:
Deborah Ramini, Silvia Latini, Angelica Giuliani, Giulia Matacchione, Jacopo Sabbatinelli, Emanuela Mensà, Maria Giulia Bacalini, Paolo Garagnani, Maria Rita Rippo, Giuseppe Bronte, Massimiliano Bonafè, Maurizio Cardelli, Fabiola Olivieri
Publikováno v:
Cells, Vol 11, Iss 23, p 3799 (2022)
One of the main challenges of current research on aging is to identify the complex epigenetic mechanisms involved in the acquisition of the cellular senescent phenotype. Despite some evidence suggested that epigenetic changes of DNA repetitive elemen
Externí odkaz:
https://doaj.org/article/600f728ad07846ad9b74fcd11a4dc9d7
Autor:
Caterina Gianni, Giuseppe Bronte, Angelo Delmonte, Marco Angelo Burgio, Kalliopi Andrikou, Manlio Monti, Cecilia Menna, Giovanni Luca Frassineti, Lucio Crinò
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Lung cancer is a complex disease with many subtypes. However, histochemical characteristics, and genetic mutation determinations are contributing to better define therapeutic targets and new drugs. Although this guarantees patients the po
Externí odkaz:
https://doaj.org/article/0f1b7f03c86348ed874f72983a9e218e